A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinethazone
Fimasartan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Fimasartan.
Quinethazone
Azilsartan medoxomil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Azilsartan medoxomil.
Quinethazone
Saralasin
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Saralasin.
Quinethazone
Tasosartan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Tasosartan.
Quinethazone
Saprisartan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Saprisartan.
Quinethazone
Forasartan
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Forasartan.
Kava
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefaloridine.
Kava
Polymyxin B
The risk or severity of adverse effects can be increased when Cefaloridine is combined with Polymyxin B.
Kava
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Cefaloridine.
Kava
Troxerutin
The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cefaloridine.
Kava
Dabigatran
The therapeutic efficacy of Dabigatran can be decreased when used in combination with Cefaloridine.
Kava
Edetate calcium disodium anhydrous
The therapeutic efficacy of Edetate calcium disodium anhydrous can be decreased when used in combination with Cefaloridine.
Kava
Tocopherylquinone
The therapeutic efficacy of Tocopherylquinone can be decreased when used in combination with Cefaloridine.
Kava
Saruplase
The therapeutic efficacy of Saruplase can be decreased when used in combination with Cefaloridine.
Kava
Melagatran
The therapeutic efficacy of Melagatran can be decreased when used in combination with Cefaloridine.
Kava
Brinase
The therapeutic efficacy of Brinase can be decreased when used in combination with Cefaloridine.
Kava
Protein S human
The therapeutic efficacy of Protein S human can be decreased when used in combination with Cefaloridine.
Kava
Gabexate
The therapeutic efficacy of Gabexate can be decreased when used in combination with Cefaloridine.
Kava
Monteplase
The therapeutic efficacy of Monteplase can be decreased when used in combination with Cefaloridine.
Kava
Nafamostat
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefaloridine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3